SABBY MANAGEMENT, LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 27 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$147,000
-76.5%
99,000
-76.7%
0.02%
-75.8%
Q4 2021$625,000
-22.6%
425,0140.0%0.09%
-16.5%
Q3 2021$808,000
-31.5%
425,014
+0.9%
0.11%
-34.3%
Q2 2021$1,179,000421,2000.17%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 1,010,000$1,919,0001.00%
Murchinson Ltd. 320,947$610,0000.30%
SABBY MANAGEMENT, LLC 425,014$808,0000.11%
Kepos Capital LP 700,000$1,330,0000.09%
Antara Capital LP 303,000$576,0000.04%
ZEKE CAPITAL ADVISORS, LLC 93,800$178,0000.01%
Warberg Asset Management LLC 26,000$49,0000.01%
Shay Capital LLC 20,000$38,0000.01%
WELLS FARGO & COMPANY/MN 122$00.00%
NORTHERN TRUST CORP 15,714$30,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders